These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2104998)

  • 21. [Risk of infection in hemotherapy].
    Sibrowski W; Wüllenweber J
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():60-3. PubMed ID: 8000255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen.
    MMWR Recomm Rep; 1996 Mar; 45(RR-2):1-9. PubMed ID: 8604210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HIV antigen determination with the enzyme immunoassay].
    Stute R
    Beitr Infusionsther; 1988; 21():157-60. PubMed ID: 2462967
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
    Ling AE; Robbins KE; Brown TM; Dunmire V; Thoe SY; Wong SY; Leo YS; Teo D; Gallarda J; Phelps B; Chamberland ME; Busch MP; Folks TM; Kalish ML
    JAMA; 2000 Jul; 284(2):210-4. PubMed ID: 10889595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen detection for human immunodeficiency virus.
    Harry DJ; Jennings MB; Yee J; Carlson JR
    Clin Microbiol Rev; 1989 Jul; 2(3):241-9. PubMed ID: 2670189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico.
    Volkow P; Perez-Padilla R; del-Rio C; Mohar A
    Rev Invest Clin; 1998; 50(3):221-6. PubMed ID: 9763887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of AIDS on blood transfusion services in South Africa.
    Grobbelaar BG
    Med Law; 1992; 11(7-8):495-500. PubMed ID: 1302768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands.
    van Hulst M; Hubben GA; Sagoe KW; Promwong C; Permpikul P; Fongsatitkul L; Glynn DM; Sibinga CT; Postma MJ
    Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should we do another test? Decision making in blood banking.
    Hanson M
    Clin Lab Med; 1996 Dec; 16(4):883-93. PubMed ID: 8974200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood bank association not liable for tainted transfusion.
    AIDS Policy Law; 2000 Jan; 15(1):9. PubMed ID: 11367227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of additional blood screening tests in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; Bonsel GJ; van Hout BA
    Transfusion; 2012 Mar; 52(3):478-88. PubMed ID: 21880046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfusion-related AIDS litigation: permitting limited discovery from blood donors in single donor cases.
    Kunin PB
    Cornell Law Rev; 1991 May; 76(4):927-61. PubMed ID: 10111164
    [No Abstract]   [Full Text] [Related]  

  • 33. Benefits of HIV screening of blood transfusions in Zambia.
    Foster S; Buvé A
    Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study.
    Mohammed Y; Bekele A
    BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. India: HIV banks.
    Kandela P
    Lancet; 1991 Aug; 338(8764):436-7. PubMed ID: 1678096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.
    Ward JW; Holmberg SD; Allen JR; Cohn DL; Critchley SE; Kleinman SH; Lenes BA; Ravenholt O; Davis JR; Quinn MG
    N Engl J Med; 1988 Feb; 318(8):473-8. PubMed ID: 3422337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the incubation time distribution and expected number of cases of transfusion-associated acquired immune deficiency syndrome.
    Kalbfleisch JD; Lawless JF
    Transfusion; 1989 Oct; 29(8):672-6. PubMed ID: 2799890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
    Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
    N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV antigen determination in blood donors. Report on a field study in Austria].
    Rosmanith P; Reissigl H; Bergmann H; Baumgarten K
    Beitr Infusionsther; 1988; 21():161-3. PubMed ID: 2462968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.